期刊文献+

Castleman病的免疫表型和基因重排分析 被引量:24

Immunophenotype and clonality analyses in Castleman's disease
在线阅读 下载PDF
导出
摘要 目的探讨Castleman病(Castleman's disease,CD)的临床病理特点,通过对其免疫组化及基因重排结果的分析以提高对该病的认识。方法对12例Castleman病进行组织学、免疫组化和基因重排分析,着重探讨其免疫表型及克隆性基因重排的特点。结果 12例Castleman病患者中,男性4例,女性8例,年龄8~71岁。组织病理学分型:透明血管型(hyaline vasculartype,HVCD)4例,浆细胞型(plasma cell type,PCCD)5例,混合型(mixed cell type,Mixed CD)3例。HVCD表现为淋巴滤泡生发中心与淋巴窦大部分消失,滤泡间小动脉增生伴透明变性,且插入滤泡中心内;外套层淋巴细胞层次显著增多并呈同心圆状排列。PCCD的小动脉的透明变性和外套层同心圆状改变不明显,淋巴窦尚存,滤泡间有大量成熟浆细胞增生。混合型则兼有上述两者的改变。免疫组化结果显示,无论HVCD或PCCD,滤泡内均有CD21和CD68阳性的滤泡树状突细胞(FDC)增生,滤泡套细胞层内CD57的限制性表达,以及滤泡间组织细胞与吞噬细胞的增生。此外,血管内皮抗原CD31、CD34均弥漫表达,HVCD滤泡内的CD31、CD34阳性血管密度高于PCCD;PCCD滤泡间有大量CD138阳性的浆细胞,而在HVCD中几乎不表达。基因重排结果:12例中8例为Ig与TCR基因重排阴性,有4例局限型Castleman病患者基因重排呈阳性反应,其中1例为IgL重排阳性,1例为IgH和IgK基因重排阳性,1例为TCRD与TCRG基因重排阳性,1例为IgH和TCRB基因重排均阳性。结论除根据组织学特征之外,免疫组化染色有助于Castleman病的病理诊断和组织学分型,尤其对组织学特征不典型的病例可进行有效的鉴别诊断,免疫球蛋白基因和TCR基因重排分析可明确病变是否有克隆性增生或恶性转化。 Purpose To investigate the clinicopathological,immunophenotype and clonality of Castleman's disease(CD).Methods Twelve cases of CD,including 8 females and 4 males with ages ranging from 8 to 74 years,were collected for immunohistochemistry and immunoglobulin(Ig) and T-cell receptor(TCR) gene rearrangement analysis.Results Among 12 cases,8 cases were localized type CD,and 4 cases were multicentric type CD.Histologically,4 cases were hyalinovascular variants(HVCD),5 cases were plasma cell variants(PCCD),and the other 3 cases were mixed type(mixed CD).The involved lymph nodes consisted of numerous regressively transformed follicles,which showed marked layering of small lymphocytes in an "onion-skin" fashion,surrounding one or several central hyalinized vessels in HVCD,but were not obvious in PCCD.Instead,PCCD usually showed abundant plasma cells between the interfollicular areas.Immunohistochemically,HVCD and PCCD showed similar mixed B and T cell immunophenotypes,accompanied by CD31 and CD34 positive and proliferating vasculatures,CD68 and CD163 positive and proliferating interfollicular mononuclear/macrophagic cells,and CD21 and CD68 positive but CD35 negative follicular dendritic cells.In addition,PCCD was rich in CD138 positive plasma cells arranged in "sheet-like" pattern among the interfollicular areas,whereas in HVCD,CD138 were normally negative.Most cases(8/12) showed polyclonal B-and T-cell populations,as demonstrated by Ig heavy chain and TCR gene rearrangement analysis.However,two patients had a clonal rearrangement of the Ig genes,one was positive in the TCR gene rearrangement,and one had both IG and TCR gene clonal rearrangements.Conclusion Castleman's disease is typically a multiclonal hyperplasia disorder.Immunohistochemistry and gene rearrangement analysis can be used in the diagnosis and differential diagnosis of the disease.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2011年第4期361-366,375,共7页 Chinese Journal of Clinical and Experimental Pathology
关键词 CASTLEMAN病 免疫组织化学 基因重排 Castleman's disease immunohistochemistry gene rearrangement
  • 相关文献

参考文献17

  • 1Castleman B,Iverson L,Menendez V P.Localized mediastinal lymphnode hyperplasia resembling thymoma[J].Cancer,1956,9(4):822-30.
  • 2Cousar J B,Casey T T,Macon W R,et al.Lymph nodes[M] //Sternberg S S.Diagnostic Surgical Pathology.4th ed.Philadelphia:Lippincott Williams & Wilkins,2004:788-90.
  • 3Collins G L,Wallis-Crespo M C,Gilbert-Barness E.Pathology teach and tell:Castleman's disease[J].Fetal Pediatr Pathol,2004,23(1):65-9.
  • 4Bowne W B,Lewis J J,Filippa D A,et al.The management of unicentric and multicentric Castleman's disease:a report of 16 cases and a review of the literature[J].Cancer,1999,85(3):706-17.
  • 5Akdogan O,Sarikaya Y,Dere H,et al.Castleman's disease of the bilateral parotid gland:a case report[J].B-ENT,2006,2(4):185-7.
  • 6van Dongen J J,Langerak A W,Bruggemann M,et al.Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations:report of the BIOMED-2 concerted action BMH4-CT98-3936[J].Leukemia,2003,17(12):2257-371.
  • 7Swerdlow S H,Campo E,Harris N L,et al.WHO classification of tumours of haematopoietic and lymphoid tissues[M].4th ed.Lyon:IARC Press,2008:258-9.
  • 8Peh S C,Shaminie J,Poppema S,Kim L H.The immunophenotypic patterns of follicle centre and mantle zone in Castleman's disease[J].Singapore Med J,2003,44(4):185-91.
  • 9Kinney M C,Hummell D S,Villiger P M,et al.Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease[J].J Clin Immunol,1994,14(6):382-90.
  • 10Nishi J,Maruyama I.Increased expression of vascular endothelial growth factor (VEGF) in Castleman′s disease:proposed pathomechanism of vascular proliferation in the affected lymph node[J].Leuk Lymphoma,2000,38(3-4):387-94.

同被引文献153

引证文献24

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部